Book Rubella IgG Test in Bhubaneswar

The Rubella IgG test is a blood test that measures the level of Immunoglobulin G antibodies against the Rubella virus, commonly known as German measles. Unlike IgM antibodies which indicate recent or active infection, IgG antibodies develop two to three weeks after initial exposure and persist lifelong, serving as reliable markers of long-term immunity acquired either through past natural infection or vaccination. The primary clinical purpose of this test is therefore to determine whether an individual is immune to rubella rather than actively infected. Rubella is a viral infection that causes mild illness in children and adults, typically presenting with a characteristic rash, low-grade fever, and lymphadenopathy. However, its most serious consequence is Congenital Rubella Syndrome, a devastating condition that occurs when a non-immune pregnant woman contracts rubella infection during the first trimester. Primary rubella infection in early pregnancy can cause severe foetal damage including congenital heart defects, cataracts, sensorineural deafness, intellectual disability, and intrauterine growth restriction, with the risk of foetal damage exceeding 85 percent when infection occurs in the first eight weeks of gestation. In India, rubella vaccination has been integrated into the national immunisation programme through the Measles-Rubella vaccine, yet a significant proportion of women of reproductive age remain susceptible due to incomplete vaccination coverage in earlier cohorts. The test is performed on a small blood sample drawn from a vein and completed in under five minutes.

Doctors prescribe a Rubella IgG test in the following situations: Assessing pre-conception immunity in women planning pregnancy where confirming rubella IgG positivity before conception is essential, as non-immune women can be vaccinated with the MMR vaccine prior to pregnancy, providing complete protection before they conceive and eliminating the risk of congenital rubella syndrome in their future child. Screening antenatal patients during early pregnancy where rubella IgG status is a standard component of the booking blood tests and identifying non-immune pregnant women enables heightened clinical vigilance, avoidance of exposure to infected individuals, and appropriate counselling regarding the serious foetal risks of primary rubella infection. Investigating suspected rubella infection during pregnancy where a combination of rubella IgM and IgG testing, along with IgG avidity testing, helps determine whether a pregnant woman with a rash illness has experienced recent primary infection, past immunity, or vaccine-related immune response, guiding urgent specialist obstetric management. Evaluating immunity status in healthcare workers, teachers, childcare staff, and other professionals with high exposure risk where rubella immunity documentation is required as part of occupational health assessments and non-immune individuals are offered vaccination to protect both themselves and vulnerable patient populations. Confirming vaccine response following MMR immunisation in individuals where documentation of seroconversion is required, particularly in healthcare settings, or where prior vaccination history is uncertain and immunity status needs to be established before potential pregnancy or occupational exposure. Investigating congenital rubella syndrome in newborns with characteristic features including cardiac defects, cataracts, hearing loss, and purpuric skin lesions where serological testing of the infant and mother helps establish whether intrauterine rubella infection was the causative event.

The Rubella IgG test measures the concentration of IgG class antibodies against the Rubella virus in the blood, expressed in International Units per millilitre (IU/mL). The widely accepted protective immunity threshold is greater than or equal to 10 IU/mL, though some laboratories and clinical guidelines use 15 IU/mL as the threshold for confirmed protective immunity. Immune (10 IU/mL and Above) A result at or above 10 IU/mL indicates the presence of protective rubella antibodies, confirming immunity through either past natural infection or prior vaccination. This is a reassuring finding in women of reproductive age and pregnant women, indicating that the risk of primary rubella infection and its associated foetal complications is negligible. Equivocal (4 to 9 IU/mL) An equivocal result falls below the confirmed immunity threshold and represents an indeterminate zone where protection cannot be reliably guaranteed. In women planning pregnancy or currently pregnant, this result warrants repeat testing, clinical review, and for non-pregnant women, consideration of MMR vaccination followed by serological confirmation of seroconversion before attempting conception. Non-Immune (Below 4 IU/mL) A result below 4 IU/mL indicates absence of protective rubella antibodies and confirmed susceptibility to infection. Non-pregnant women in this category should receive MMR vaccination and wait at least one month before attempting conception. Pregnant women who test non-immune require urgent counselling, heightened exposure precautions, and close monitoring throughout pregnancy as vaccination cannot be administered during pregnancy.

No fasting is required for the Rubella IgG test, as food and fluid intake do not affect antibody concentrations in the blood. The test can be performed at any time of day and is commonly ordered as part of a routine antenatal or pre-conception blood panel without any specific dietary preparation needed beforehand. Inform your doctor about any recent MMR or rubella vaccination received within the past four to six weeks, as recently administered live vaccines can transiently influence antibody levels and the timing of testing relative to vaccination affects how results are interpreted, particularly when confirming vaccine-induced seroconversion. If you are currently experiencing symptoms of a rash illness or have been in recent contact with a confirmed rubella case, inform your healthcare provider before testing. In such scenarios, your doctor may request both rubella IgM and IgG alongside IgG avidity testing to accurately determine whether any infection is recent or longstanding, which carries entirely different clinical implications particularly during pregnancy. Staying well hydrated before the blood draw facilitates easier venous access and a smooth collection experience.

If you are booking through the SecondMedic platform the Rubella IgG test price in Bhubaneswar can cost you around Rs. 410. You may also consider booking a comprehensive TORCH panel that includes Rubella IgG and IgM alongside Toxoplasma, CMV, and Herpes antibodies for a complete pre-conception or antenatal infectious disease profile at a bundled price on SecondMedic.

SecondMedic offers convenient home sample collection for the Rubella IgG test in Bhubaneswar, making it easy to get tested without visiting a diagnostic centre. Home collection is available free of charge for orders above Rs. 300. A trained phlebotomist will visit your preferred address between 7 AM and 10 PM, seven days a week, including Sundays and public holidays. Your blood sample is processed at NABL-accredited partner laboratories, and your report is delivered within 24 hours directly to your WhatsApp and email.